IP Library Granted Patent US 9,149,537
Granted Patent B2
US 9,149,537 · App. 13/880,829 · Granted Oct 6, 2015

Compositions and methods for the treatment of traumatic brain injury

Inventors: Dong Wang (Omaha, NE); Matthew Kelso (Papillion, NE)
Assignee: BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
A61K47/48176A61K45/06A61K49/00A61K49/0008A61K47/48A61K47/48007A61K47/48023A61K47/48169A61K47/48192
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,149,537
App. No.
13/880,829
Granted
Oct 6, 2015
Kind
B2
Abstract

Compositions and methods for the inhibition and/or prevention of traumatic brain injury and the symptoms associated with it are provided.

Claims (11)

1. A method for reducing in a subject the pathology associated with traumatic injury to the brain, wherein said subject has sustained a traumatic brain injury, said method comprising administering to the subject at least one polymer and at least one pharmaceutically acceptable carrier,

wherein said polymer comprises at least one anti-inflammatory agent conjugated to the polymer,

wherein said polymer is a N-(2-hydroxypropyl) methacrylamide (HPMA) copolymer having the structure:

wherein m and n are independently from about 1 to about 1000, wherein R is a linker, and wherein said linker is an alkyl having one to about 15 carbons or a peptide having 1 to about 10 amino acids.

2. The method of claim 1 , wherein said composition is administered to the subject within one day of the traumatic brain injury.

3. The method of claim 2 , wherein said composition is administered to the subject within about 6 hours of the traumatic brain injury.

4. The method of claim 1 , wherein said polymer further comprises at least one imaging agent.

5. The method of claim 1 , wherein said composition is administered intravenously, intraperitoneally, or intramuscularly.

6. The method of claim 1 , wherein said HPMA copolymer is

7. The method of claim 1 further comprising the administration of at least one additional anti-inflammatory agent.

8. The method of claim 1 , wherein said composition is administered intravenously.

Assignments (1)
CONFIRMATORY LICENSE Recorded Sep 11, 2013
From: UNIVERSITY OF NEBRASKA MEDICAL CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 031202/0115 →
Continuity (2)
Provisional Application 61410213 · Nov 4, 2010
Related Publication 20130243696A1 · Sep 19, 2013